Search alternatives:
significant case » significant cause (Expand Search), significant based (Expand Search), significant change (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
case based » made based (Expand Search), game based (Expand Search), rate based (Expand Search)
significant case » significant cause (Expand Search), significant based (Expand Search), significant change (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
case based » made based (Expand Search), game based (Expand Search), rate based (Expand Search)
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
34
Scenario analysis for daratumumab using a cumulative cost-based price per year per vial.
Published 2024Subjects: -
35
-
36
-
37
-
38
-
39
-
40